Phase
Condition
Spinal Cord Injuries
Treatment
STDP stimulation
Dalfampridine
Placebo
Clinical Study ID
Ages 18-85 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Male and females between ages 18-85 years
SCI 6 months post injury
Spinal Cord injury at or above L2
ASIA A, B, C, or D, complete or incomplete
The ability to perform a small visible contraction with dorsiflexion and hip flexormuscles
Exclusion
Exclusion Criteria:
Uncontrolled medical problems including pulmonary, cardiovascular or orthopedicdisease
Any history of renal impairment
Any debilitating disease prior to the SCI that caused exercise intolerance
Premorbid, ongoing major depression or psychosis, altered cognitive status
History of head injury or stroke
Vascular, traumatic, tumoral, infectious, or metabolic lesion of the brain, evenwithout history of seizure, and without anticonvulsant medication
History of seizures or epilepsy
Receiving drugs acting primarily on the central nervous system, which lower theseizure threshold (see appendix 2)
Pregnant females
If a women of child bearing age is unsure of the pregnancy, and does not want totake the pregnancy test
Ongoing cord compression or a syrinx in the spinal cord or who suffer from a spinalcord disease such as spinal stenosis, spina bifida, MS, or herniated disk
Metal plate in skull
Individuals with scalp shrapnel, cochlear implants, or aneurysm clips
Individuals taking Bupropion, Dolutegravir, Lacosamide, Trilaciclib, or PR Intervalprolonging drugs
Study Design
Study Description
Connect with a study center
Shirley Ryan Abilitylab
Chicago, Illinois 60611
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.